Financial statements Onkologiczna Antyrak
Balance sheet of Onkologiczna Antyrak
Company age:
Age:
7 y. 4 m. 3 d.
Balance sheet data of ONKOLOGICZNA ANTYRAK
|
Year
|
2018
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 135 229,83 | 114 649,67 | 134 617,71 | 114 110,57 | 147 058,24 |
| A. Fixed assets | 0,00 | 25 200,00 | 41 516,67 | 32 116,67 | 22 716,67 |
| B. Current assets | 135 229,83 | 89 449,67 | 93 101,04 | 81 993,90 | 124 341,57 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | - | - | - | - |
| Total liabilities | 135 229,83 | 114 649,67 | 134 617,71 | 114 110,57 | 147 058,24 |
| A. Equity | 134 628,66 | 113 925,21 | 78 035,76 | 114 075,57 | 147 026,24 |
| B. Liabilities and provisions for liabilities | 601,17 | 724,46 | 56 581,95 | 35,00 | 32,00 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 601,17 | 724,46 | 56 581,95 | 35,00 | 32,00 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.